Loading...
XLON
AGR
Market cap2.07bUSD
Oct 03, Last price  
47.48GBP
1D
0.38%
1Q
-5.04%
Jan 2017
-16.35%
IPO
-9.35%
Name

Assura PLC

Chart & Performance

D1W1MN
XLON:AGR chart
No data to show
P/E
9.30
P/S
8.40
EPS
0.05
Div Yield, %
5.27%
Shrs. gr., 5y
5.57%
Rev. gr., 5y
10.51%
Revenues
184m
+16.48%
7,016,00016,123,000047,571,00055,761,00062,119,00034,100,00037,100,00039,900,00051,100,00061,000,00071,100,00086,100,000102,400,000111,500,000121,000,000137,300,000152,000,000157,800,000183,800,000
Net income
166m
P
-12,499,00018,900,0000-108,763,000-8,682,00015,072,000-60,700,00014,100,00035,000,00037,200,00027,900,00095,300,00071,800,00084,000,00078,900,000108,300,000155,900,000-119,200,000-28,800,000166,000,000
CFO
111m
+7.91%
2,190,000760,000149,0005,295,000-11,746,0002,859,00013,400,00012,900,0007,900,00016,900,00022,900,00039,000,00049,900,00072,900,00066,300,00077,400,00094,600,00094,100,000102,400,000110,500,000
Dividend
Sep 05, 20240.84 GBP/sh

Profile

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
IPO date
Jan 28, 2015
Employees
86
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
183,800
16.48%
157,800
3.82%
152,000
10.71%
Cost of revenue
22,000
28,500
26,600
Unusual Expense (Income)
NOPBT
161,800
129,300
125,400
NOPBT Margin
88.03%
81.94%
82.50%
Operating Taxes
100
700
Tax Rate
0.08%
0.56%
NOPAT
161,800
129,200
124,700
Net income
166,000
-676.39%
(28,800)
-75.84%
(119,200)
-176.46%
Dividends
(93,300)
(85,500)
(88,900)
Dividend yield
6.39%
6.80%
6.15%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
70,100
300
400
Long-term debt
1,480,100
1,258,400
1,252,200
Deferred revenue
3,800
4,200
35,700
Other long-term liabilities
100
46,800
Net debt
1,494,900
1,205,800
1,116,300
Cash flow
Cash from operating activities
110,500
102,400
94,100
CAPEX
(300)
(2,800)
(15,200)
Cash from investing activities
(284,100)
(97,700)
(130,400)
Cash from financing activities
196,300
(87,300)
(89,200)
FCF
166,000
60,600
128,600
Balance
Cash
55,300
33,200
118,000
Long term investments
19,700
18,300
Excess cash
46,110
45,010
128,700
Stockholders' equity
398,600
309,400
894,600
Invested Capital
3,145,090
2,685,090
2,794,800
ROIC
5.55%
4.72%
4.39%
ROCE
5.07%
4.74%
4.41%
EV
Common stock shares outstanding
3,159,793
2,970,682
2,958,385
Price
0.46
9.22%
0.42
-13.39%
0.49
-26.97%
Market cap
1,460,456
16.17%
1,257,193
-13.03%
1,445,467
-22.33%
EV
2,955,356
2,462,993
2,561,767
EBITDA
161,800
129,600
125,600
EV/EBITDA
18.27
19.00
20.40
Interest
41,600
27,100
31,200
Interest/NOPBT
25.71%
20.96%
24.88%